fda approved glp-1 drugs Overview of structure, date of approval and dosage frequency of GLP-1 Drug Savings: A Complete
Description
By Michael S
The clinical results so far are hard to ignore
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), initially developed for glycaemic control in patients with type 2 diabetes, have demonstrated significant cardiometabolic benefits
Treatment results vary from person to person
In recent years, glucagon-like peptide 1 receptor agonists (GLP-1RAs) have become central in the treatment of type 2 diabetes (T2D)
Records were reviewed for patient characteristics and medication type and doses
